×
+ All Categories
Log in
English
Français
Español
Deutsch
The top documents tagged [fda slide]
Home >
fda slide
Asthma Physiology and Natural Support Options Catherine Oshin Nat 307 Module 11 Discuss the physiology of asthma. What natural support options are available?
213 views
csupharmacol.com Pharmacology Chapter 1.Introduction About Pharmacology Chapter 2.Pharmacokinetics What the body does to a drug Chapter 3.Pharmacodynamics.
220 views
Monika Kawohl Principal Statistical Programmer Accovion GmbH, Marburg, Germany New FDA Documents - Discussion of Implementation Considerations.
222 views
ADaM IG, May 2008 ADaM Implementation Guide: Its Almost Here. Are You Ready? Sandra Minjoe Principal Statistical Programmer Analyst Genentech, Inc.
228 views
1 Off-Label Use of Medications in Workers Compensation Matthew Foster, PharmD, BCPS PMSI Clinical Services.
213 views
Prosecutorial Perspective on Off- Label Promotion Virginia Gibson Assistant U.S. Attorney National Pharma AudioConference, October 26, 2004.
214 views
The Constitutional Convention May-September 1787 Goal: Amend the Articles of Confederation Ideas behind the Constitution: –The Enlightenment –3-part government.
224 views
Labeling claims for patient- reported outcomes (A regulatory perspective) FDA/Industry Workshop Washington, DC September 16, 2005 Lisa A. Kammerman, Ph.D.
212 views
Surrogate Markers and its role in the Drug Development Process Aloka G. Chakravarty, Ph.D. Director, Biologics Therapeutics Statistical Staff
[email protected]
.
230 views
1 Revising FDAs Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests FDA/Industry Statistics Workshop September 28-29, 2006.
221 views
A History of Stats at the FDA Mary A. Foulkes, Ph.D. U.S. Food And Drug Administration Office of Biostatistics and Epidemiology Center for Biologics Evaluation.
218 views
1 Improving FDA/Industry Interactions: Suggestions from FDA/CDER Statisticians Rafia Bhore, Ph.D. Janice Derr, Ph.D. FDA / CDER / Office of Biostatistics.
222 views
Next >